Bronchopulmonary C-fiber afferents are characterized by their distinct sens
itivity to chemical stimuli in the airways or pulmonary circulation. Respon
ses evoked by activating these afferents are mediated by both central refle
x pathways and by local or axon reflexes involving the release of tachykini
ns from sensory endings. Bronchopulmonary C-fiber stimulation reflexly redu
ces tidal volume and increases respiratory rate, constricts the airways, in
creases mucus secretion in the airways, and is associated with coughing. Ca
rdiovascular effects include bradycardia, a fall in cardiac output, and bro
nchial vasodilation that increases airway blood flow despite systemic hypot
ension. In animals, C-fiber stimulation inhibits skeletal muscle activity,
and in humans, is accompanied by burning and choking sensations in the thro
at and upper chest. Recent studies have identified additional physiologic a
nd pharmacologic stimuli to these afferents, such as hydrogen ions, adenosi
ne, reactive oxygen species, and hyperosmotic solutions. Furthermore, incre
asing evidence indicates that the excitability of these afferents is enhanc
ed by the local release of certain autocoids (e.g. PGE(2)) during airway in
flammation. These findings further indicate that vagal C-fiber endings in t
he lungs and airways play an important role in regulating the cardiopulmona
ry functions under both normal and abnormal physiologic conditions. (C) 200
1 Elsevier Science B.V. All rights reserved.